Please assess the completion status of the following clinical trial:

Trial Title: Sternotomies and PectoIntercostal Fascia Blocks in Fast-Track Cardiac Anesthesiology

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients presenting to the Mazankowski Heart Institute for operations via full midline sternotomy, i.e.: coronary artery bypass grafting, and/or single valve repair or single valve replacement who are expected to be fast track candidates post-operatively.~* patients scheduled for cardiac bypass grafting and/or single valve surgery requiring cardiopulmonary bypass.~Exclusion Criteria:~* Unstable or fluctuating cardiac condition (acute MI, HF, tamponade, type A dissection, ongoing refractory arrhythmia, LVEF \<40%, massive transfusion protocol, reinstitution of CPB or other mechanical support)~* Alternative surgical approach (e.g. thoracotomy, mini sternotomy)~* Repeat sternotomy or emergency surgery~* Pregnancy or lactation~* Age \<18~* Chronic pain~* Tolerance to opioids~* Active alcohol misuse disorder, IVDU or cannabis use \>1g/d~* Allergy to local anesthetics~* Inability to provide informed consent~* High doses of steroids pre-operatively (\>10 mg prednisone/day)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: EXPERIMENTAL): This group of patients will undergo placement of US guided pectointercostal fascia blocks.
- Placebo (Type: PLACEBO_COMPARATOR): The control group patients will receive the same intraoperative analgesia management. A PIF block will not be performed, instead, a peripheral nerve block catheter will be secured to the skin surface and connected to a CADD™ pump. As the catheter is taped to the skin surface the control group patients will not be exposed to the risks of peripheral nerve block placement.

Based on this trial design, predict the completion outcome and termination type (if applicable).